We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$24.4B
Cap. Flow %
5.19%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Technology 2.31%
2 Consumer Discretionary 1.61%
3 Financials 1.35%
4 Healthcare 1.15%
5 Communication Services 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEI
11826
PUT
DELISTED
Camber Energy, Inc
CEI
$32.1K ﹤0.01%
20,300
-75,200
-79% -$130K
XBIO icon
11827
Xenetic Biosciences
XBIO
$8.95M
$32.1K ﹤0.01%
7,782
+5,278
+211% +$25.6K
BYFC icon
11828
Broadway Financial
BYFC
$110M
$31.9K ﹤0.01%
3,797
-3,823
-50% -$36K
HRTG icon
11829
CALL
Heritage Insurance Holdings
HRTG
$1.02B
$31.7K ﹤0.01%
+10,300
New +$26.8K
AKBA icon
11830
PUT
Akebia Therapeutics
AKBA
$248M
$31.7K ﹤0.01%
56,600
+35,100
+163% +$26.8K
SEEL
11831
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$31.7K ﹤0.01%
12
-35
-74% -$102K
OGI
11832
CALL
Organigram Holdings
OGI
$179M
$31.5K ﹤0.01%
12,300
-2,600
-17% -$8.25K
LVOX
11833
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$31.5K ﹤0.01%
10,189
-54,142
-84% -$144K
TOUR
11834
PUT
Tuniu
TOUR
$52.5M
$31.4K ﹤0.01%
+1,680
New +$33.7K
MMLP icon
11835
PUT
Martin Midstream Partners
MMLP
$89.2M
$31.2K ﹤0.01%
11,400
-16,900
-60% -$48.3K
WATT icon
11836
CALL
Energous
WATT
$63.9M
$31K ﹤0.01%
96
-7
-7% -$2.98K
ATOS icon
11837
CALL
Atossa Therapeutics
ATOS
$26.3M
$31K ﹤0.01%
2,867
-9,673
-77% -$108K
ORMP icon
11838
Oramed Pharmaceuticals
ORMP
$216M
$30.9K ﹤0.01%
14,189
-171,417
-92% -$545K
FCUV icon
11839
Focus Universal
FCUV
$6.77M
$30.9K ﹤0.01%
+31
New +$44.8K
TLS icon
11840
PUT
Telos
TLS
$330M
$30.9K ﹤0.01%
+12,200
New +$49.8K
APPH
11841
PUT
DELISTED
AppHarvest, Inc. Common Stock
APPH
$30.8K ﹤0.01%
50,500
-87,400
-63% -$105K
VIOT
11842
Viomi Technology
VIOT
$53.4M
$30.8K ﹤0.01%
+29,859
New +$36.4K
MREO
11843
Mereo BioPharma
MREO
$44.6M
$30.5K ﹤0.01%
43,089
+29,989
+229% +$27K
LCI
11844
CALL
DELISTED
Lannett Company, Inc.
LCI
$30.3K ﹤0.01%
17,400
+13,925
+401% +$30.7K
ARQQ icon
11845
CALL
Arqit Quantum
ARQQ
$351M
$30.2K ﹤0.01%
864
-7,936
-90% -$375K
IGC icon
11846
IGC Pharma
IGC
$31.4M
$30.1K ﹤0.01%
88,722
+10,582
+14% +$3.97K
LSF icon
11847
Laird Superfood
LSF
$46.2M
$30.1K ﹤0.01%
37,148
-42,703
-53% -$44.9K
BIOR
11848
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$30K ﹤0.01%
1,083
+230
+27% +$7.8K
BIRD icon
11849
PUT
Smartbird Inc
BIRD
$28.1M
$30K ﹤0.01%
1,250
-1,175
-48% -$54.2K
GMDA
11850
PUT
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$30K ﹤0.01%
37,000
+6,800
+23% +$9.94K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $24.4B of net new capital in Q1 2023, opening 2,075 new positions and adding to 5,756 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $1.62B trimmed.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.